MTOR and cancer: The oncogenic signalling RAS/RAF/ERK and PI3K/AKT/mTOR (mammalian target of rapamycin), regulate several key-players of the Pol I complex such as RRN3, UBF, and SL-1, resulting in the enhancement of rRNA synthesis in cancer [37].